Now showing items 21-26 of 26
Ischemia-Modified Albumin in Acute Decompensated Heart Failure: IMA-HF Study
(LIPPINCOTT WILLIAMS & WILKINS, 2012)
CA125 levels among patients with advanced heart failure: An emerging independent predictor for survival
(ELSEVIER IRELAND LTD, 2010)
Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
(AVES YAYINCILIK, 2010)
Objective: Leyosimendan is a relatively new inotropic agent. Unlike other inotropic agents, Levosimendan does not increase cellular calcium intake, so that, does not cause intracellular calcium overload and related ...
Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure
(ARQUIVOS BRASILEIROS CARDIOLOGIA, 2010)
Background: Levosimendan is a novel inotropic agent that enhances cardiac contractility without increasing cellular calcium intake, so that it is not supposed to cause intracellular calcium overload and related arrhythmias. ...
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure
(OXFORD UNIV PRESS, 2013)
The aim of this study was to assess the prevalence of abnormal liver function tests (LFTs) and the associated clinical profile and outcome(s) in acute decompensated heart failure (ADHF) patients. Alteration in LFTs is a ...
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association
Heart failure (HF) is a complex clinical syndrome with multiple interactions between the failing myocardium and cerebral (dys-)functions. Bi-directional feedback interactions between the heart and the brain are inherent ...